Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
04 mars 2022 06h00 HE
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million ...
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
23 févr. 2022 16h45 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
17 févr. 2022 16h10 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
20 janv. 2022 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
09 janv. 2022 18h00 HE
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
23 déc. 2021 17h16 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results
11 nov. 2021 18h15 HE
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2021 total revenue of $6.9 million and commercial revenue of $6.3 million Reaffirms full-year 2021 commercial revenue outlook of at least $24.0 million, representing at least...
Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference
29 oct. 2021 07h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
19 oct. 2021 07h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer
05 oct. 2021 17h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation...